Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Intuitive Surgical (ISRG) · oqro.io/stocks/ISRG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Questions about Intuitive Surgical insider trading
Have Intuitive Surgical insiders bought shares recently?
No open-market purchase by an insider of Intuitive Surgical was filed in the last 90 days. The latest on record was on Nov 19, 2010.
How often do Intuitive Surgical insiders buy and sell shares?
Since 2006, Intuitive Surgical insiders reported 2 open-market purchases and 2,390 sales on Forms 4 and 5, with purchases in 1 different year, most recently 2010.
Who is selling Intuitive Surgical stock?
In the last 90 days, 6 insiders of Intuitive Surgical (ISRG) reported 24 open-market sales worth $20.3M in total on SEC Form 4. The largest seller by value was Gary S Guthart, with $13.6M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Do members of Congress trade ISRG?
Yes. Members of Congress disclosed 5 trades in Intuitive Surgical (ISRG) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Sen. Alan Armstrong, Rep. Gilbert Ray Cisneros Jr. (CA31), Sen. Markwayne Mullin.
When does Intuitive Surgical report its next results?
Intuitive Surgical's next results are expected on Jan 20, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
ISRG price and disclosed activity
−23.0% (−$125.82) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $546.77 on Nov 18, 2025 to $420.95 on Nov 18, 2026 (−23.0%). Disclosed in this range: 0 insider trades, 77 pre-arranged insider sales, 5 Congress trades, and 318 13F position changes for 4 quarters ending in it.
$300$500$600$700$420.95
DecJan 2026FebMarAprMayJunJulAugSepOctNov
13F holdings, by quarter end
Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.Show the 82 trades in this range as a list
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Equipment company based in Sunnyvale, California.
Last 12 months
−23.0%
S&P 500 +10.6% over the same dates
Market value
$146B
Close of Nov 18, 2026 × shares outstanding (per ADS where it applies)
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 7.06M shares sold short (2.0% of shares outstanding), −3.6% vs the previous count, 2.5 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Latest results: quarter ending Sep 30, 2026
Revenue
$3.05B
+21.7% vs the same quarter a year earlier
Free cash flow, last 12 months
$3.6B
This quarter $1.11B, a year earlier $736M
Net debt
—
Debt —, cash $2.98B, at Sep 30, 2026
Net income, last 12 months
$2.96B
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 20, 2026.
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Written by software from the filings listed below · Nov 13, 2026
Insiders. In the 30 days to Nov 13, 2026, insiders filed 0 open-market purchases and 13 open-market sales, about $19.7M, in 10 filings, by 6 people. Intuitive Surgical on OQRO
3 more points, with the facts they come from, are in OQRO Pro.
Insiders of Intuitive Surgical reported 2 open-market purchases and 2,390 sales since 2006; purchases in 2010.
Year
Bought
Sold
2026
—
$49.1M69×69 trades
2025
—
$128M99×99 trades
2024
—
$167M145×145 trades
2023
—
$95.3M71×71 trades
2022
—
$41M21×21 trades
2021
—
$142M73×73 trades
2020
—
$121M71×71 trades
2019
—
$78.4M73×73 trades
2018
—
$233M104×104 trades
2017
—
$141M132×132 trades
2016
—
$107M66×66 trades
2015
—
$115M48×48 trades
2014
—
$40.9M32×32 trades
2013
—
$34.1M17×17 trades
2012
—
$173M61×61 trades
2011
—
$92.3M257×257 trades
2010
$531K2×2 trades
$64.3M273×273 trades
2009
—
$24.6M159×159 trades
2008
—
$36.7M92×92 trades
2007
—
$48.9M302×302 trades
2006
—
$76.4M225×225 trades
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
When insiders usually buy
Last results
Oct 20, 2026
More than 30 days ago
Next results, expected
Jan 20, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Intuitive Surgical's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Intuitive Surgical's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Layoff notices (WARN)
Last 24 months
1 notice filed with state agencies, covering 331 workers in total. Employers must warn the state ahead of a plant closing or mass layoff at a site.
Official WARN lists from California, Texas, New York, Florida, Illinois and Washington only; notices filed in other states are not shown. Matched on the employer name as filed, so a notice filed under an unrelated subsidiary name can be missing. Dates are the notice date (Washington: the date the state received it).
105 certified in FY2026 Q3, vs 117 a year earlier. 105 positions in total, median offered wage $167K a year.
Supervisor - Software Quality · 3Business Systems Analyst · 2Clinical Development Engineer · 2Component Engineer · 2FPGA Engineer · 2
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Late-stage clinical trials
1 active phase 3 trial and 0 active phase 2 trials led by this company, mostly in ureter injury. The ones with the nearest registered primary completion date still ahead:
Source: ClinicalTrials.gov, studies whose lead sponsor is the company or a listed subsidiary. “Primary completion” is the sponsor's own registry date for the last main data collection. It is not an approval date, it says nothing about the result, and it is often revised.
People read Intuitive Surgical's Wikipedia article about 160 times a day over the last week, close to the 170 on a usual day of the three months before.
May 14, 2026Busiest day: 440 views on Jul 17, 2026Nov 18, 2026
Views of the article Intuitive Surgical, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
FDA, last 12 months
14 approvals or clearances and 13 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Risk factors in the annual report
Latest annual report filed Feb 3, 2026, compared with the one filed Jan 31, 2025. Read the filing
No longer listed (1 heading from the year before)
WE MAY INCUR LOSSES ASSOCIATED WITH CURRENCY FLUCTUATIONS AND MAY NOT BE ABLE TO EFFECTIVELY HEDGE OUR EXPOSURE.
Legal proceedings (Item 3)
The information included in Note 8 to the Consolidated Financial Statements included in Part II, Item 8 of this report is incorporated herein by reference.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 3, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Short sale volume: 44.4% of the volume reported to FINRA over the last 20 trading days was marked short, close to its 1-year average of 43.3%. FINRA daily files, to Nov 18, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Off-exchange trading: 48.6% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (27.7% on ATS, 20.9% with other brokers), above its 26-week average of 45.1%. Weeks of Oct 5 to Oct 30, 2026.
Week of May 4ATSOther off-exchangeFull height = all shares tradedWeek of Oct 26
Largest ATS: UBS ATS (13.4%), INTELLIGENT CROSS LLC (13.0%), SIGMA X2 (10.9%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
OQRO Intelligence
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Insiders. In the 12 months to Nov 19, 2026, insiders of Intuitive Surgical filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 77 open-market sales (about $62.7M, in 46 filings, by 9 people). One Form 4 can list many transactions. In the 12 months before that, they filed 0 open-market purchases (about $0, in 0 filings) and 104 open-market sales (about $116M, in 45 filings). (Intuitive Surgical on OQRO)
Congress. Members of Congress filed 5 disclosures on Intuitive Surgical in the 12 months to Nov 19, 2026: 5 purchases and 0 sales, by 3 members. In the 12 months before that: 20 disclosures. The largest range: Sen. Markwayne Mullin, $15,001 to $50,000, filed Jan 16, 2026.
Funds and stakes. Fund 13F filings recorded in the 12 months show 183 new or larger positions and 141 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings. 1 federal contract award to the company was recorded in the 12 months, with about $100K obligated so far. A contract amount is what the agency obligated, not revenue. 6 lobbying reports naming the company were posted in the 12 months, reporting about $540K.
Company reports, price and press. Intuitive Surgical filed a Form 8-K on Nov 2, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors. The company's own opening sentence of that report reads: "On October 29, 2026, the Board of Directors (the 'Board') of Intuitive Surgical, Inc. (the 'Company') approved an increase in the size of the Board from ten to eleven members and appointed Aaron Martin to fill the resulting vacan..."
Who holds it. 2,241 funds reported a stake in Intuitive Surgical in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (9.8% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (7.5% of the value reported), STATE STREET CORP (5.2% of the value reported).
Attention. The English Wikipedia article on Intuitive Surgical was read about 163 times a day in the 7 days to Nov 18, 2026, against a usual 169 a day over the 90 days before. Reads measure attention, not buying or selling.
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. An 8-K item says what the company reported, not what it means for the share price.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
In the 12 months to Nov 19, 2026, insiders of Intuitive Surgical filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 77 open-market sales (about $62.7M, in 46 filings, by 9 people). One Form 4 can list many transactions.
In the 12 months before that, they filed 0 open-market purchases (about $0, in 0 filings) and 104 open-market sales (about $116M, in 45 filings).
The largest sale: Gary S Guthart, Executive Chair of the Board o, about $13M, filed Dec 2, 2025.
Congress
Members of Congress filed 5 disclosures on Intuitive Surgical in the 12 months to Nov 19, 2026: 5 purchases and 0 sales, by 3 members. In the 12 months before that: 20 disclosures.
The largest range: Sen. Markwayne Mullin, $15,001 to $50,000, filed Jan 16, 2026.
Funds and stakes
Fund 13F filings recorded in the 12 months show 183 new or larger positions and 141 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings
1 federal contract award to the company was recorded in the 12 months, with about $100K obligated so far. A contract amount is what the agency obligated, not revenue.
6 lobbying reports naming the company were posted in the 12 months, reporting about $540K.
FDA records list 13 device clearances, 7 recalls for Intuitive Surgical between Nov 19, 2025 and Nov 19, 2026; the latest, on Oct 30, 2026: device clearance for da Vinci Xi Surgical System (IS4000);da Vinci X Surgical System (IS4200) (510(k) clearance, special: Substantially Equivalent).
ClinicalTrials.gov shows 1 study sponsored by the company updated in the period; the latest, "IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery" (Phase 3, status recruiting), was updated on Aug 5, 2026, with primary completion listed for 2027-04-30.
FINRA short interest for ISRG on the settlement date of Oct 30, 2026 was 7,058,186 shares (-3.65% on the previous report), about 2.55 days of average volume.
In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: ARK Investment Management (increased, 4,024 shares); the largest that shrank: Coatue Management (reduced, 166,113 shares); Bridgewater Associates (reduced, 7,764 shares). A 13F is a quarter-end snapshot with no trade date.
Company reports, price and press
Intuitive Surgical filed a Form 8-K on Nov 2, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "On October 29, 2026, the Board of Directors (the 'Board') of Intuitive Surgical, Inc. (the 'Company') approved an increase in the size of the Board from ten to eleven members and appointed Aaron Martin to fill the resulting vacan..."
Intuitive Surgical filed a Form 8-K on May 28, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
The company's own opening sentence of that report reads: "Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the 'Company') and begin serving as Senior Vice President of Global Business Operation..."
Intuitive Surgical filed a Form 8-K on May 4, 2026 (Items 5.02, 5.07, 7.01) that OQRO classes as: changed a top executive or board member, and held a shareholder vote (and 1 more item).
The company's own opening sentence of that report reads: "Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the 'Board') of Intuitive Surgical, Inc. (the 'Company') previously adopted, subject to stockholder approval,..."
Press coverage listed by Finnhub: "Could Intuitive Surgical Stock Turn $10,000 Into $12,200?" (Yahoo, Nov 19, 2026).
Press coverage listed by Finnhub: "ISRG EPS Climbs 25% to $3: Is Innovation Driving Profitable Growth?" (Yahoo, Nov 17, 2026).
Press coverage listed by Finnhub: "If You Invested $100 In Intuitive Surgical Stock 20 Years Ago, You Would Have This Much Today" (Benzinga, Nov 13, 2026).
ISRG closed at $420.95 on Nov 18, 2026, the last session on or before the end of the period.
From Oct 19, 2026 to Nov 18, 2026, the close moved from $433.18 to $420.95, a change of −2.8%.
Who holds it
2,241 funds reported a stake in Intuitive Surgical in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (9.8% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (7.5% of the value reported), STATE STREET CORP (5.2% of the value reported).
Attention
The English Wikipedia article on Intuitive Surgical was read about 163 times a day in the 7 days to Nov 18, 2026, against a usual 169 a day over the 90 days before. Reads measure attention, not buying or selling.
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
Since Nov 17, 2025, ISRG is down 23.0% and the index fund is up 9.7%: 33 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much ISRG moves
A usual day
±1.2%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14)
3.9%Average distance between the low and the high of a session, over the last 14.
Largest one-day fall
−14.1%Jul 17, 2026
Largest one-day rise
+9.4%Nov 4, 2026
Deepest fall of the year
−44.0%From the close of Jan 6, 2026 to Jul 23, 2026.
Days of 5% or more
9Out of 252 sessions, in either direction.
Beta 0.9(1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).